CAROL KESSEL: Open Payments
NPI 1609490952 · WAUKEGAN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 32 payments from 9 companies in 2025. Trend: 2023 $1,307 · 2024 $515 · 2025 $754
Food & beverage: $754
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $480 |
| Lundbeck LLC | 3 | $74 |
| Genentech USA, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $38 |
| PFIZER INC. | 2 | $35 |
| Supernus Pharmaceuticals, Inc. | 1 | $30 |
| Neos Therapeutics, LP | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: QULIPTA, UBRELVY, VYEPTI, VRAYLAR, Ocrevus Zunovo, KISUNLA, NURTEC ODT, Qelbree.
Industry payments across IL — which companies pay providers there.
